Bio Rad Laboratories Inc.

Hercules, CA

UEI
KBN4ZDJ47ZB9
CAGE
019S4
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, BIO - RAD Laboratories Gesellschaft MIT Beschraenkter Haftung, ranks:

and 1 more

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
4000 Alfred Nobel Dr, Hercules, CA 94547, USA
Website
bio-rad.com
Founded
1952
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $3,799
FY2026 $2,671,875
FY2025 $2,084,034
FY2024 $3,401,319
FY2023 $2,939,296

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Defense Health Agency $2,296,630
2 Department of Veterans Affairs $194,435
3 Department of Agriculture $64,471
4 Department of Health and Human Services $45,322
5 Environmental Protection Agency $40,213
6 Department of the Interior $21,218
7 Department of Justice $13,385

Contract vehicles

No active vehicles.

2 expired vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Mriglobal MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) Procurement of AutoDG + QX200 Droplet Digital PCR System 75N93024C00002 $193,864

Similar vendors

About the company

Bio-Rad Laboratories Inc., headquartered in Hercules, California, manufactures clinical diagnostic instrumentation, quality control reagents, immunoassay analyzers, and PCR systems that it sells to federal healthcare, research, and military medical facilities as a large-business prime contractor competing full-and-open without set-aside participation. The vendor is a subsidiary of Bio-Rad Laboratories, Inc., a global manufacturer of life science research and clinical diagnostic products.

Over the past several years, Bio-Rad has accumulated 4,211 prime awards (100% of the portfolio) spanning 93 federal agencies, with combined potential value of $201.1 million and $74.3 million in obligated dollars. Recent work includes a $3.4 million October 2025 purchase order from the Defense Health Agency for pathology testing supplies, a $1.75 million September 2025 delivery order for serological automated analyzers supporting HIV and Hepatitis C testing in military entrance processing, and a $574.8 million August 2023 VA purchase order for quality control reagents running through July 2028. Representative smaller orders span immunology testing supplies ($157.5 thousand, VA Greater Los Angeles Healthcare System, September 2026), blood bank reagents ($43.8 thousand, Huntington VA Medical Center, October 2026), and quality control materials for laboratory validation ($301.6 thousand, Indian Health Service, September 2026). Award volume has remained relatively flat year over year—34 awards in 2023, 21 in 2024, 27 in 2025, and 16 through October 2026—with eight awards (combined potential value $1 million) reaching ultimate completion within the next twenty-four months.

The vendor's customer base concentrates heavily in military and Veterans Affairs medical operations. The top five funding agencies by award count are the Indian Health Service (211 awards, $4.4 million), Army Medical Command (174 awards, $39.7 million), Navy Bureau of Medicine and Surgery (129 awards, $8 million), and two Veterans Integrated Service Networks—VISN 2 (89 awards, $8 million) and VISN 5 (79 awards, $729 thousand)—collectively representing 16% of recent awards. However, the Defense Health Agency and Army Medical Command dominate dollar concentration, accounting for 56% of combined potential value across $49.9 million and $39.7 million respectively. Bio-Rad holds a single-award indefinite delivery contract with the Defense Health Agency valued at $6.9 million through September 2030 for serological automated analyzers supporting military entrance processing, with delivery orders consistently drawn for HIV and Hepatitis C testing supplies and reagents. The vendor also maintains a single-award indefinite delivery contract with Veterans Integrated Service Network 2 valued at $39.1 thousand through December 2027 for GEENIUS HIV testing systems, and a $447.9 thousand Blanket Purchase Agreement with the Air Force (through October 2026) for GEENIUS HIV test kits and reagents. A $200 thousand BPA established with the Office of Acquisitions and Grants in July 2026 supports general laboratory instrumentation and diagnostic systems through July 2031.

Bio-Rad's capability portfolio centers on NAICS codes 325413 (In-Vitro Diagnostic Substance Manufacturing, 654 awards), 333314 (Analytical Laboratory Instrument Manufacturing, 413 awards), and 325414 (Biological Product Manufacturing, 113 awards), spanning PSC codes for laboratory equipment and supplies (1,752 awards), in vitro diagnostic substances and reagents (1,166 awards), and medical/surgical instruments (474 awards). Work performed in California facilities (Hercules, Rodeo, Brea, Parlier) and subordinate locations (Silver Spring, Maryland; Fort Sam Houston, Texas; Albany, New York; and others nationwide) includes analyzer rentals, preventative maintenance agreements, reagent supply, equipment calibration, and related clinical support services. The vendor holds a single sub-award relationship documented in the source: Mriglobal engaged Bio-Rad as a subcontractor in November 2024 for procurement of AutoDG and QX200 Droplet Digital PCR systems supporting a Mycobacterium tuberculosis quality assessment program.

Quick answers

Is Bio Rad Laboratories Inc. registered in SAM.gov?

Yes. Bio Rad Laboratories Inc.'s SAM.gov registration is active through August 21, 2027.

Which contract vehicles does Bio Rad Laboratories Inc. hold?

Bio Rad Laboratories Inc. holds a place on 2 federal contract vehicles, including FSS-66-III and FSS-65-VII.

How much has Bio Rad Laboratories Inc. received in federal contracts?

Federal contracts obligated $2,084,034 to Bio Rad Laboratories Inc. in fiscal year 2025 and $11,100,323 in fiscal years 2023 through 2027.

How does Bio Rad Laboratories Inc. rank among federal contractors?

Bio Rad Laboratories Inc.'s parent company, BIO - RAD Laboratories Gesellschaft MIT Beschraenkter Haftung, ranked #23 in NAICS 325413, #26 in PSC W066 and #30 in PSC 6550 in FY2025.

What is Bio Rad Laboratories Inc.'s most recent federal award?

Bio Rad Laboratories Inc.'s most recent federal contract award is Blood bank reagents contract for the huntington VA medical center. New base plus four option year contract (36C24527P0013), from Veterans Integrated Service Network 5 (VHA), on October 18, 2026.

On GovTribe

See Bio Rad Laboratories Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors